The healthcare industry spent an estimated $3.7 billion on artificial intelligence solutions in 2025, according to Statista. Executives cite clinical decision support, revenue cycle optimization, and administrative automation as their top priorities. Yet a striking pattern has emerged: roughly 75% of healthcare AI pilots never reach production, per Gartner’s 2025 analysis of digital health deployments.
The conventional explanation blames model accuracy, data quality, or clinician resistance. But after observing deployment patterns across hospital systems in multiple states, a different bottleneck has become clear. The real barrier is not the model. It is the platform.
Most healthcare organizations approach AI as a model problem. They invest heavily in data science teams, purchase or build sophisticated algorithms, and run promising pilots. Then everything stalls. The model works in a notebook. It fails in production. Not because the algorithm is wrong, but because there is no infrastructure to deploy it safely, monitor it continuously, and prove compliance at every step.
This is the platform gap, and it is costing health systems millions.
Consider what happens when a hospital deploys a clinical decision support tool powered by machine learning. The model itself may perform well on retrospective data. But in production, it must integrate with EHR workflows without disrupting clinical operations. It must log every inference for audit purposes. It must degrade gracefully when upstream data feeds fail. It must demonstrate compliance with HIPAA, and increasingly, with emerging state-level AI transparency laws. None of these requirements are model problems. They are platform engineering problems.
Financial services solved a similar challenge over the past decade. When banks deployed AI for BSA/AML compliance, suspicious activity monitoring, and fraud detection, they discovered that model accuracy alone was insufficient for regulators. The Office of the Comptroller of the Currency and FinCEN required explainability, audit trails, and governance frameworks that operated independently of any single model. The industry responded by building internal platforms that separated model development from model governance.
Healthcare is facing the same inflection point, with higher stakes. A false positive in fraud detection triggers a review. A false positive in clinical decision support can trigger a treatment decision. The governance infrastructure must be proportionally more rigorous.
Three platform engineering disciplines are emerging as critical for healthcare AI deployment.
First, policy-as-code. Rather than relying on manual compliance reviews, leading organizations are encoding regulatory requirements directly into their deployment pipelines. When CMS updates reimbursement rules or a state passes new AI disclosure requirements, policy-as-code frameworks allow organizations to propagate changes across every deployed model simultaneously. This reduces the compliance lag from months to hours.
Second, automated audit trails. Every model inference, every data access event, and every configuration change must be logged immutably. This is not optional. The HHS Office for Civil Rights has signaled that AI-driven decisions involving protected health information will face the same scrutiny as traditional data handling. Organizations without comprehensive audit infrastructure are building compliance debt that will eventually come due.
Third, internal developer platforms for clinical AI. These platforms abstract away the complexity of healthcare-specific requirements, including FHIR integration, consent management, de-identification pipelines, and role-based access controls, so that data science teams can focus on model development rather than reinventing compliance infrastructure for every project.
The organizations getting this right share a common trait: they treat the platform as the product, not the model. The model is a component that can be swapped, retrained, or replaced. The platform is the durable asset that ensures every model operates within safe and compliant boundaries.
This shift has measurable consequences. According to KLAS Research, health systems with mature deployment infrastructure report 40% faster time-to-production for AI initiatives compared to those building bespoke deployment pipelines for each project. The cost savings compound: standardized platforms reduce the marginal cost of deploying each subsequent model.
The implications for health system CIOs and CTOs are clear. Stop leading with the model. Start leading with the platform. Before evaluating another AI vendor or approving another pilot, ask a different set of questions: Do we have deployment infrastructure that can handle production-grade AI? Can we demonstrate compliance for every model in production, at any time, to any regulator? Can our data science teams deploy a new model without rebuilding governance from scratch?
If the answer to any of these is no, the next investment should not be another algorithm. It should be the platform that makes every algorithm safe to deploy.
The healthcare industry does not have a model shortage. It has a platform deficit. Closing that gap is the most consequential infrastructure decision health systems will make this decade.
About Piyoosh Rai
Piyoosh Rai is the Founder and CEO of The Algorithm, a technology firm specializing in AI platform engineering for regulated industries including healthcare and financial services. Based in Littleton, Colorado.
